NOVARTIS AG (NVSEF)
Clinical trial NCT04645589 updates: 1. completion date: 2025-06-13 → 2025-08-13 2. primary completion date: 2025-06-13 → 2025-08-13 3. enrollment: 72 → 69 participants
Clinical trial NCT04645589 updates: 1. completion date: 2025-06-13 → 2025-08-13 2. primary completion date: 2025-06-13 → 2025-08-13 3. enrollment: 72 → 69 participants
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical